Gilead Sciences is a biopharmaceutical company that established itself as a leader in antiviral therapeutics, with foundational products in HIV and hepatitis C treatment, and has expanded into oncology and inflammation through acquisitions and internal pipeline development. The company's engineering challenges include building computational platforms for antiviral and immunology research, developing data systems that support long-term patient outcome tracking across chronic disease therapies, and scaling the analytics infrastructure that informs both clinical development decisions and commercial strategy. Their technology organization supports molecular modeling workflows, clinical data management, manufacturing systems, and the regulated data pipelines required for a company with a global patient base. Gilead's hiring patterns reflect a biopharmaceutical company investing in computational research capabilities, with demand for data engineers, bioinformatics scientists, and software engineers who can build the platforms connecting drug discovery with real-world treatment outcomes.
| Location | Listings |
|---|